Pages that link to "Q39535980"
Jump to navigation
Jump to search
The following pages link to KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update (Q39535980):
Displaying 50 items.
- Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Q24188192) (← links)
- Chinese medicinal herbs for treating diabetic kidney disease (Q24192995) (← links)
- Chinese medicinal herbs for treating diabetic kidney disease (Q24243310) (← links)
- Interactions between kidney disease and diabetes: dangerous liaisons (Q26740630) (← links)
- Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease (Q26741451) (← links)
- The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies (Q26744317) (← links)
- Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes (Q26744419) (← links)
- Recent advances in managing and understanding diabetic nephropathy (Q26745900) (← links)
- Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease (Q26747131) (← links)
- Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control (Q26766259) (← links)
- Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician (Q26782607) (← links)
- Ethnic/Race Diversity and Diabetic Kidney Disease (Q26796594) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q26798326) (← links)
- Endothelin Blockade in Diabetic Kidney Disease (Q26799476) (← links)
- Hypoglycemia in Patients with Diabetes and Renal Disease (Q26799515) (← links)
- Present and future in the treatment of diabetic kidney disease (Q26864133) (← links)
- Management of diabetic kidney disease: Recent advances (Q27009775) (← links)
- Diabetic kidney disease: a report from an ADA Consensus Conference (Q27012546) (← links)
- Diabetic kidney disease: from physiology to therapeutics (Q27021392) (← links)
- Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials (Q27022613) (← links)
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. (Q27687851) (← links)
- Vascular calcification: When should we interfere in chronic kidney disease patients and how? (Q28071582) (← links)
- Update on the treatment of type 2 diabetes mellitus (Q28073342) (← links)
- Improvements in the Management of Diabetic Nephropathy (Q28080717) (← links)
- Adverse safety events in patients with Chronic Kidney Disease (CKD). (Q30245199) (← links)
- Clinical therapeutic strategies for early stage of diabetic kidney disease. (Q30363683) (← links)
- Pleiotropic effects of type 2 diabetes management strategies on renal risk factors. (Q30374407) (← links)
- Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes. (Q30833537) (← links)
- Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study (Q30840219) (← links)
- Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease (Q31025919) (← links)
- Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort (Q31107244) (← links)
- Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease (Q33576711) (← links)
- The effects of glucose-lowering therapies on diabetic kidney disease (Q33583220) (← links)
- An evidence-based shared decision making programme on the prevention of myocardial infarction in type 2 diabetes: protocol of a randomised-controlled trial (Q33592897) (← links)
- Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats. (Q33628045) (← links)
- Acute kidney injury in a diabetic haemophiliac: one step at a time. (Q33629093) (← links)
- Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study (Q33632319) (← links)
- Surveillance of Dialysis Events: one-year experience at 33 outpatient hemodialysis centers in China (Q33671077) (← links)
- Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis (Q33687578) (← links)
- The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease (Q33698333) (← links)
- Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease (Q33698768) (← links)
- Kidney dysfunction in patients with pulmonary arterial hypertension (Q33738621) (← links)
- Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy (Q33747852) (← links)
- Anti-hypertensive drugs in children and adolescents (Q33772773) (← links)
- Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. (Q33776181) (← links)
- How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study (Q33779315) (← links)
- Changes in metformin use in chronic kidney disease (Q33783138) (← links)
- Management of diabetes mellitus in patients with chronic kidney disease (Q33792375) (← links)
- Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings. (Q33827573) (← links)
- Chronic kidney disease and osteoporosis: evaluation and management (Q33833414) (← links)